ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Synapsa Bacopa Monnieri Extract

Also known as: Brahmi, Water hyssop, Synapsa Bacopa Monnieri Extract, Bacopa monnieri

Overview

Bacopa monnieri (L.) Wettst., commonly known as Brahmi or Water hyssop, is a traditional Ayurvedic herb primarily recognized for its cognitive-enhancing and neuroprotective properties. Native to wetlands in India and parts of Asia, it has been utilized for centuries in traditional medicine. Standardized extracts, such as Synapsa, are formulated to improve memory, attention, and overall cognitive function. Research indicates its potential in addressing cognitive decline and neurodegenerative conditions like Parkinson's disease. The scientific understanding of Bacopa monnieri is robust, with numerous randomized controlled trials and meta-analyses supporting its efficacy, though variations in extract preparation and study designs can influence outcomes.

Benefits

Bacopa monnieri offers several evidence-based benefits, primarily in cognitive function and neuroprotection. Its main effect is the improvement of cognitive function, specifically the speed of attention and memory retention, as supported by meta-analyses of randomized controlled trials (RCTs) showing statistically significant effects with moderate effect sizes. These benefits are typically observed after 12 weeks of consistent supplementation. Secondary benefits include significant neuroprotection, mediated through its antioxidant, anti-inflammatory, and anti-apoptotic mechanisms. Preclinical studies suggest potential in Parkinson's disease models by reducing α-synuclein aggregation and dopaminergic neurodegeneration. Bacopa monnieri is beneficial for healthy adults seeking cognitive enhancement and for older adults or individuals experiencing cognitive decline due to its neuroprotective properties. The strength of evidence for cognitive enhancement is high, based on multiple human clinical trials and meta-analyses.

How it works

Bacopa monnieri exerts its cognitive and neuroprotective effects through a multifaceted mechanism of action. It acts as an antioxidant, reducing oxidative stress in neural tissues, which is crucial for neuronal health. The herb modulates key neurotransmitters, including acetylcholine, serotonin (5-HT), and dopamine, thereby enhancing synaptic transmission and plasticity. Specifically, it increases acetylcholine availability by inhibiting acetylcholinesterase and activating choline acetyltransferase. Bacopa monnieri also contributes to neuroprotection by reducing β-amyloid aggregation, a hallmark of Alzheimer's pathology, and by upregulating brain-derived neurotrophic factor (BDNF) and activating CREB signaling, which promotes neurogenesis. Furthermore, it exhibits anti-inflammatory effects by inhibiting pro-inflammatory cytokines like TNF-α and IL-6.

Side effects

Bacopa monnieri is generally considered safe with a low toxicity profile in both human and animal studies. The most commonly reported side effects are mild and infrequent, primarily involving gastrointestinal discomfort such as nausea, stomach cramps, and increased bowel movements, as well as occasional fatigue. These side effects typically occur in less than 5% of users. While no major drug interactions have been definitively reported, caution is advised when combining Bacopa monnieri with cholinergic medications due to its acetylcholine-modulating properties, or with sedative medications, as it may potentiate their effects. Long-term safety data are somewhat limited, and specific contraindications are not well-established. Due to insufficient evidence regarding its safety during pregnancy and lactation, pregnant or breastfeeding women are advised to avoid its use. Individuals with pre-existing gastrointestinal conditions should consult a healthcare professional before starting supplementation.

Dosage

Effective dosages of standardized Bacopa monnieri extract in clinical trials typically range from 300 to 450 mg per day. It is crucial that the extract is standardized to contain at least 20% bacosides to ensure consistent efficacy. The minimum effective dose appears to be around 300 mg/day. For optimal cognitive benefits, chronic administration is recommended, with effects usually observed after at least 8-12 weeks of consistent daily use. Timing of supplementation with meals may enhance absorption and reduce the likelihood of mild gastrointestinal discomfort. It is important to adhere to products standardized for bacoside content, as this ensures consistent bioavailability and therapeutic effect. There are no clearly defined upper limits or safety thresholds beyond the recommended daily dose, but exceeding the recommended dosage is not advised without professional guidance.

FAQs

Is Synapsa Bacopa monnieri extract effective?

Yes, multiple randomized controlled trials and meta-analyses support its effectiveness in enhancing cognitive functions, particularly attention and memory.

Are there safety concerns with Bacopa monnieri?

It is generally safe with mild, infrequent side effects like gastrointestinal discomfort. Long-term safety data are still being gathered, and pregnant/breastfeeding women should avoid use.

How long does it take to see effects from Bacopa monnieri?

Cognitive improvements typically require consistent daily use for 8-12 weeks before noticeable effects appear.

Does Bacopa monnieri help with neurodegenerative diseases?

Preclinical and some clinical evidence suggest neuroprotective effects, but more high-quality human trials are needed to confirm its role in treating neurodegenerative diseases.

Research Sources

  • https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2022.972379/full – This systematic review explores the neuroprotective effects of Bacopa monnieri, particularly in Parkinson's disease models. It highlights the antioxidant and anti-inflammatory mechanisms, though notes that much of the evidence for neurodegenerative diseases is preclinical, requiring further human trials.
  • https://www.nature.com/articles/s41598-020-80045-2 – This meta-analysis and review investigates Bacopa monnieri's neuroprotective effects via the BDNF/CREB pathway and its impact on cognitive improvements. It combines findings from both animal and human studies, showing benefits in working memory and verbal learning, despite some heterogeneity in study designs.
  • https://pubmed.ncbi.nlm.nih.gov/24252493/ – This meta-analysis of randomized controlled trials assessed Bacopa monnieri's impact on cognitive function. It concluded that Bacopa monnieri improved the speed of attention with a moderate effect size and was generally safe and well-tolerated, despite some variability in extract standardization across studies.
  • https://magistralbr.caldic.com/storage/product-files/1219933901.pdf – This document provides an overview of Bacopa monnieri, detailing its traditional uses, chemical constituents, and pharmacological activities. It supports the herb's role in cognitive enhancement and neuroprotection, emphasizing its safety profile and mechanisms of action.
  • https://www.liebertpub.com/doi/10.1089/rej.2013.1431 – This research explores the safety profile and potential drug interactions of Bacopa monnieri. It suggests a low toxicity in human and animal models, with mild and infrequent side effects, while advising caution with certain medications due to its pharmacological activities.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC7937913/ – This article discusses the optimal dosing guidelines for Bacopa monnieri, emphasizing the importance of standardized extracts and chronic administration. It highlights that effective doses typically range from 300-450 mg/day of extract standardized to 20% bacosides for cognitive benefits.
  • https://journals.aboutscience.eu/index.php/dti/article/view/1417 – This study contributes to the understanding of Bacopa monnieri's efficacy, particularly focusing on its impact on memory and attention. It reinforces the findings from other research regarding the herb's cognitive-enhancing properties and its general safety for use.

Supplements Containing Synapsa Bacopa Monnieri Extract

Memory500 by Purity Products
70

Memory500

Purity Products

Score: 70/100
Synapsa Powder by Nootropics Depot
88

Synapsa Powder

Nootropics Depot

Score: 88/100
Synapsa Capsules 320 mg by Nootropics Depot
78

Synapsa Capsules 320 mg

Nootropics Depot

Score: 78/100

Recommended Articles

Top Nootropics for Memory: 2024-2025 Guide

Top Nootropics for Memory: 2024-2025 Guide

Specific nootropics have shown to significantly enhance memory in healthy adults, with emerging trends and personalized approaches for 2024-2025.

Safe Nootropics for Memory & Focus in 2025

Safe Nootropics for Memory & Focus in 2025

The safest nootropics for long-term memory and focus improvement in 2025 include well-researched compounds and emerging substances with minimal side effects.

Safe Nootropic Stacking for Focus

Stacking nootropics can improve focus if done safely, considering dosages and sleep impact.

Top Nootropics for Exam Focus: A Student Guide

Top Nootropics for Exam Focus: A Student Guide

Certain nootropics have been scientifically proven to improve focus and cognitive functions, beneficial for students during exams.